サマリー

The global migraine treatment devices market is projected to register a robust growth in the forecast period, 2023-2027. The younger population's rising complaints of migraine pain and underlying disorders caused by factors such as prolonged screen time or other environmental variables are driving the demand for migraine treatment devices over the next five years. Migraine pain is a severe type of headache that typically gives the patient a localized, excruciatingly painful, and throbbing feeling on one side of the head. Vomiting, nausea, and sensitivity to light and sound are further symptoms. Acupuncture therapies, progressive muscle relaxation, and thermal therapy are a few examples of therapeutic methods. Additionally, ongoing research and creative product development for medical devices used to treat migraines is expected to fuel the market growth. Rising government assistance and escalating investment in the therapeutic sector and the healthcare industry is likely to boost the market growth.
The development of therapeutic areas such as the release of the External Trigeminal Nerve Stimulation (e-TNS) Device, Single Pulse Transcranial Magnetic Stimulator (sTMS), and GammaCore Non-Invasive Vagus Nerve Stimulator, among others, have collectively contributed to the availability of advanced products for the treatment of migraine and supports the growth of the global market for migraine treatment devices over the next five years.
The global migraine treatment devices market is segmented into type, site, product type, therapy, distribution channel, end user, regional distribution, and competitive landscape. Based on type, the market is divided into external trigeminal nerve stimulation (e-TNS) device, single pulse transcranial magnetic stimulator (sTMS), gammaCore non-invasive vagus nerve stimulators, and others. External trigeminal nerve stimulation (e-TNS) device is expected to capture the highest market share in the forecast period, 2023-2027 as the device shows better results in the clinical trials against other devices.
The major market players operating in the global migraine treatment devices market are Theranica Bio-Electronics Ltd., CEFALY Technology, electroCore, Inc., eNeura Inc, Neurolief Ltd., Cirrus Healthcare Products LLC, Neuros Medical Inc, Salvia BioElectronics B.V.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023–2027
Objective of the Study:
• To analyze the historical growth in the market size of the global migraine treatment devices from 2017 to 2021.
• To estimate and forecast the market size of global migraine treatment devices market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the global migraine treatment devices market based on type, site, product type, therapy, distribution channel, end user, region, and company.
• To identify the dominant region or segment in the global migraine treatment devices market.
• To identify drivers and challenges for the global migraine treatment devices market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global migraine treatment devices market.
• To identify and analyze the profiles of leading players operating in the global migraine treatment devices market.
• To identify key sustainable strategies adopted by market players in global migraine treatment devices market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of the Global migraine treatment devices market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global migraine treatment devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Migraine Treatment Devices Market, By Type:
o External Trigeminal Nerve Stimulation (e-TNS) Device
o Single Pulse Transcranial Magnetic Stimulator (sTMS)
o gammaCore Non-Invasive Vagus Nerve Stimulator
o Others
• Migraine Treatment Devices Market, By Site:
o Handheld
o Headband
o Others
• Migraine Treatment Devices Market, By Product Type:
o Prescription
o Over The Counter
• Migraine Treatment Devices Market, By Therapy:
o Acute Therapy
o Preventive Therapy
• Migraine Treatment Devices Market, By Distribution Channel:
o Hospital Based Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Migraine Treatment Devices Market, By End User:
o Hospitals & Clinics
o Homecare
o Others
• Migraine Treatment Devices Market, By Region:
o North America
 United States
 Mexico
 Canada
o Europe
 France
 Germany
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 India
 Japan
 South Korea
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global migraine treatment devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

目次

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Migraine Treatment Devices Market
4. Executive Summary
5. Voice of Customer
5.1. Migraine Prevalence By Type (Episodic, Migraine with Aura, Others)
5.2. Number of Patients Suffering from Migraine, by Gender
5.3. Number of Patients Suffering from Migraine, by Age Group
5.4. Number of Patients Suffering from Migraine, by Region
5.5. Preference By Type
5.6. Commonly Used Preventive Drugs
5.7. Commonly Used Diagnostic Procedures
5.8. Frequency of Individuals Diagnosed With Migraine Consulting a Physician
5.9. Brand Awareness
5.10. Barriers to Adoption of Effective Migraine Treatment Options
6. Clinical Trials
6.1. Ongoing Clinical Trials
6.2. Completed Clinical Trials
6.3. Terminated Clinical Trials
6.4. Clinical Trial Analysis
7. Patent Analysis
7.1. Patent Granted (2017-2021)
7.2. Patent Applications Filed
8. List of Commercially Available Migraine Treatment Devices
9. Global Migraine Treatment Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (External Trigeminal Nerve Stimulation (e-TNS) Device, Single Pulse Transcranial Magnetic Stimulator (sTMS), gammaCore Non-Invasive Vagus Nerve Stimulator, Others)
9.2.2. By Site (Handheld, Headband, Others)
9.2.3. By Product Type (Prescription v/s Over The Counter)
9.2.4. By Therapy (Acute Therapy v/s Preventive Therapy)
9.2.5. By Distribution Channel (Hospital Based Pharmacies, Retail Pharmacies, Online Pharmacies)
9.2.6. By End User (Hospitals & Clinics, Homecare, Others)
9.2.7. By Company (2021)
9.2.8. By Region
9.3. Product Market Map
10. North America Migraine Treatment Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Site
10.2.3. By Product Type
10.2.4. By Therapy
10.2.5. By Distribution Channel
10.2.6. By End User
10.2.7. By Country
10.3. North America: Country Analysis
10.3.1. United States Migraine Treatment Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Site
10.3.1.2.3. By Product Type
10.3.1.2.4. By Therapy
10.3.1.2.5. By Distribution Channel
10.3.1.2.6. By End User
10.3.2. Mexico Migraine Treatment Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Site
10.3.2.2.3. By Product Type
10.3.2.2.4. By Therapy
10.3.2.2.5. By Distribution Channel
10.3.2.2.6. By End User
10.3.3. Canada Migraine Treatment Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Site
10.3.3.2.3. By Product Type
10.3.3.2.4. By Therapy
10.3.3.2.5. By Distribution Channel
10.3.3.2.6. By End User
11. Europe Migraine Treatment Devices Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Site
11.2.3. By Product Type
11.2.4. By Therapy
11.2.5. By Distribution Channel
11.2.6. By End User
11.2.7. By Country
11.3. Europe: Country Analysis
11.3.1. France Migraine Treatment Devices Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Site
11.3.1.2.3. By Product Type
11.3.1.2.4. By Therapy
11.3.1.2.5. By Distribution Channel
11.3.1.2.6. By End User
11.3.2. Germany Migraine Treatment Devices Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Site
11.3.2.2.3. By Product Type
11.3.2.2.4. By Therapy
11.3.2.2.5. By Distribution Channel
11.3.2.2.6. By End User
11.3.3. United Kingdom Migraine Treatment Devices Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Site
11.3.3.2.3. By Product Type
11.3.3.2.4. By Therapy
11.3.3.2.5. By Distribution Channel
11.3.3.2.6. By End User
11.3.4. Italy Migraine Treatment Devices Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Type
11.3.4.2.2. By Site
11.3.4.2.3. By Product Type
11.3.4.2.4. By Therapy
11.3.4.2.5. By Distribution Channel
11.3.4.2.6. By End User
11.3.5. Spain Migraine Treatment Devices Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Type
11.3.5.2.2. By Site
11.3.5.2.3. By Product Type
11.3.5.2.4. By Therapy
11.3.5.2.5. By Distribution Channel
11.3.5.2.6. By End User
12. Asia-Pacific Migraine Treatment Devices Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By Site
12.2.3. By Product Type
12.2.4. By Therapy
12.2.5. By Distribution Channel
12.2.6. By End User
12.2.7. By Country
12.3. Asia-Pacific: Country Analysis
12.3.1. China Migraine Treatment Devices Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Type
12.3.1.2.2. By Site
12.3.1.2.3. By Product Type
12.3.1.2.4. By Therapy
12.3.1.2.5. By Distribution Channel
12.3.1.2.6. By End User
12.3.2. India Migraine Treatment Devices Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Type
12.3.2.2.2. By Site
12.3.2.2.3. By Product Type
12.3.2.2.4. By Therapy
12.3.2.2.5. By Distribution Channel
12.3.2.2.6. By End User
12.3.3. South Korea Migraine Treatment Devices Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Type
12.3.3.2.2. By Site
12.3.3.2.3. By Product Type
12.3.3.2.4. By Therapy
12.3.3.2.5. By Distribution Channel
12.3.3.2.6. By End User
12.3.4. Japan Migraine Treatment Devices Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Type
12.3.4.2.2. By Site
12.3.4.2.3. By Product Type
12.3.4.2.4. By Therapy
12.3.4.2.5. By Distribution Channel
12.3.4.2.6. By End User
12.3.5. Australia Migraine Treatment Devices Market Outlook
12.3.5.1. Market Size & Forecast
12.3.5.1.1. By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1. By Type
12.3.5.2.2. By Site
12.3.5.2.3. By Product Type
12.3.5.2.4. By Therapy
12.3.5.2.5. By Distribution Channel
12.3.5.2.6. By End User
13. South America Migraine Treatment Devices Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Type
13.2.2. By Site
13.2.3. By Product Type
13.2.4. By Therapy
13.2.5. By Distribution Channel
13.2.6. By End User
13.2.7. By Country
13.3. South America: Country Analysis
13.3.1. Brazil Migraine Treatment Devices Market Outlook
13.3.1.1. Market Size & Forecast
13.3.1.1.1. By Value
13.3.1.2. Market Share & Forecast
13.3.1.2.1. By Type
13.3.1.2.2. By Site
13.3.1.2.3. By Product Type
13.3.1.2.4. By Therapy
13.3.1.2.5. By Distribution Channel
13.3.1.2.6. By End User
13.3.2. Argentina Migraine Treatment Devices Market Outlook
13.3.2.1. Market Size & Forecast
13.3.2.1.1. By Value
13.3.2.2. Market Share & Forecast
13.3.2.2.1. By Type
13.3.2.2.2. By Site
13.3.2.2.3. By Product Type
13.3.2.2.4. By Therapy
13.3.2.2.5. By Distribution Channel
13.3.2.2.6. By End User
13.3.3. Colombia Migraine Treatment Devices Market Outlook
13.3.3.1. Market Size & Forecast
13.3.3.1.1. By Value
13.3.3.2. Market Share & Forecast
13.3.3.2.1. By Type
13.3.3.2.2. By Site
13.3.3.2.3. By Product Type
13.3.3.2.4. By Therapy
13.3.3.2.5. By Distribution Channel
13.3.3.2.6. By End User
14. Middle East and Africa Migraine Treatment Devices Market Outlook
14.1. Market Size & Forecast
14.1.1. By Value
14.2. Market Share & Forecast
14.2.1. By Type
14.2.2. By Site
14.2.3. By Product Type
14.2.4. By Therapy
14.2.5. By Distribution Channel
14.2.6. By End User
14.2.7. By Country
14.3. MEA: Country Analysis
14.3.1. South Africa Migraine Treatment Devices Market Outlook
14.3.1.1. Market Size & Forecast
14.3.1.1.1. By Value
14.3.1.2. Market Share & Forecast
14.3.1.2.1. By Type
14.3.1.2.2. By Site
14.3.1.2.3. By Product Type
14.3.1.2.4. By Therapy
14.3.1.2.5. By Distribution Channel
14.3.1.2.6. By End User
14.3.2. Saudi Arabia Migraine Treatment Devices Market Outlook
14.3.2.1. Market Size & Forecast
14.3.2.1.1. By Value
14.3.2.2. Market Share & Forecast
14.3.2.2.1. By Type
14.3.2.2.2. By Site
14.3.2.2.3. By Product Type
14.3.2.2.4. By Therapy
14.3.2.2.5. By Distribution Channel
14.3.2.2.6. By End User
14.3.3. UAE Migraine Treatment Devices Market Outlook
14.3.3.1. Market Size & Forecast
14.3.3.1.1. By Value
14.3.3.2. Market Share & Forecast
14.3.3.2.1. By Type
14.3.3.2.2. By Site
14.3.3.2.3. By Product Type
14.3.3.2.4. By Therapy
14.3.3.2.5. By Distribution Channel
14.3.3.2.6. By End User
15. Market Dynamics
15.1. Drivers
15.2. Challenges
16. Market Trends & Developments
17. Competitive Landscape
17.1. Theranica Bio-Electronics Ltd.
17.2. CEFALY Technology
17.3. electroCore, Inc.
17.4. eNeura Inc
17.5. Neurolief Ltd.
17.6. Cirrus Healthcare Products LLC
17.7. Neuros Medical Inc
17.8. Salvia BioElectronics B.V.
18. Strategic Recommendations